Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation

Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation

Between December 2014 and March 2021, 144 patients with aortic (Ao) or mitral (Mi) paravalvular leaks (PVLs) were enrolled at 21 sites in 10 countries. Safety data were available for 137 patients, who were included in the safety analysis fraction (SAF), 93 patients with Mi PVLs and 44 patients with...

Full description

Bibliographic Details
Main Authors: Eustaquio Maria Onorato, Francesco Alamanni, Manuela Muratori, Grzegorz Smolka, Wojtek Wojakowski, Piotr Pysz, Aleksejus Zorinas, Diana Zakarkaite, Hélène Eltchaninoff, Pierre-Yves Litzer, François Godart, Patrick Calvert, Christos Christou, Abdurashid Mussayev, Bindo Missiroli, Igor Buzaev, Salvatore Curello, Tullio Tesorio, Antonio Luca Bartorelli
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
paravalvular leak
paravalvular regurgitation
aortic valve
mitral valve
transcatheter closure
long-term outcomes
Online Access:https://www.mdpi.com/2077-0383/11/7/1978

Internet

https://www.mdpi.com/2077-0383/11/7/1978

Similar Items